Ticker brief
QNRX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
29
authors 14d
22
crowd 14d
+0.27
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
· daily mean sentiment, 2026-08-28 → 2026-08-28 · now +0.33 (−1 bearish … +1 bullish)
Who spoke22
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @MrStockLockPro1 | C | -0.94 | 3 | +0.32 |
| @BioStocks | C | -3.02 | 2 | +0.17 |
| @Briefingcom | B | +0.50 | 2 | +0.15 |
| @SuperDuperInvst | C | -0.99 | 2 | +0.55 |
| @PrismMarketView | C | · | 2 | +0.33 |
| @BiopharmIQ | B | · | 2 | +0.55 |
| @timothysykes | C | -1.46 | 1 | +0.75 |
| @CrweWorld | C | · | 1 | -0.35 |
| @AlertsAndNews | C | -1.90 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @joinlegendsonly | C | -0.81 | 1 | +0.25 |
| @OTR444 | C | -1.39 | 1 | +0.25 |
| @BPharmCatalyst | C | · | 1 | +0.55 |
| @Pharmdca | C | +0.82 | 1 | +0.00 |
| @DavidScottAdams | C | -1.92 | 1 | +0.30 |
| @optionscjp | C | -1.28 | 1 | +0.50 |
| @InvestmentGuru_ | C | +0.12 | 1 | +0.50 |
| @frankyboyz | C | -2.26 | 1 | +0.70 |
| @OzmosiHealth | C | · | 1 | +0.55 |
| @EmmanuelInvest | C | -1.11 | 1 | +0.50 |
| @FintwitAi | C | +1.14 | 1 | +0.60 |
| @TheBreakoutZone | C | +1.85 | 1 | -0.40 |
Recent signals29of 29 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @MrStockLockPro1 | +0.20 | Labels a four-ticker watchlist post as a recap without new forward trade instructions. | · | tweet ↗ |
| 2026-08-28 | @BiopharmIQ | +0.50 | QNRX rose more than 20% after positive interim Phase 2/3 data | · | tweet ↗ |
| 2026-08-28 | @TheBreakoutZone | -0.40 | Summarizes realized daily trade gains and one loss. | · | tweet ↗ |
| 2026-08-28 | @FintwitAi | +0.60 | Promotes a prior alert after a realized 108% stock move. | · | tweet ↗ |
| 2026-08-28 | @BiopharmIQ | +0.60 | Biotech open summary pairs stock moves with clinical, regulatory and financing events | · | tweet ↗ |
| 2026-08-28 | @EmmanuelInvest | +0.50 | Quoin reported positive Phase 2/3 interim efficacy and safety data for QRX003. | · | tweet ↗ |
| 2026-08-28 | @PrismMarketView | +0.15 | Reports significant interim trial data, a placement up to $50M and trading volume above 27M shares. | · | tweet ↗ |
| 2026-08-28 | @PrismMarketView | +0.50 | Lists intraday percentage moves and prices for five healthcare stocks as of noon ET. | · | tweet ↗ |
| 2026-08-28 | @MrStockLockPro1 | +0.40 | Reports that QNRX reached the first target. | · | tweet ↗ |
| 2026-08-28 | @OzmosiHealth | +0.55 | Quoin reports positive interim Phase 2/3 data for QRX003. | · | tweet ↗ |
| 2026-08-28 | @SuperDuperInvst | +0.40 | Describes an exclusive licensing partnership with a $5M approval milestone and royalties. | · | tweet ↗ |
| 2026-08-28 | @frankyboyz | +0.70 | Says QNRX at 6.05 is paying strongly | · | tweet ↗ |
| 2026-08-28 | @InvestmentGuru_ | +0.50 | Summarizes six event-driven premarket gainers with clinical, earnings and capital actions. | · | tweet ↗ |
| 2026-08-28 | @MrStockLockPro1 | +0.35 | Morning watchlist provides conditional breakout entries, targets, and stops without the author's entry intent. | · | tweet ↗ |
| 2026-08-28 | @optionscjp | +0.50 | Premarket digest reports discrete trial, earnings, deal, buyback and bankruptcy catalysts. | · | tweet ↗ |
| 2026-08-28 | @DavidScottAdams | +0.30 | Identifies five stocks as positive morning movers. | · | tweet ↗ |
| 2026-08-28 | @Pharmdca | +0.00 | Notes QNRX's very low float and tiny market cap while asking how it will trade at the open. | · | tweet ↗ |
| 2026-08-28 | @SuperDuperInvst | +0.70 | Recaps an approximately 200% premarket rise. | · | tweet ↗ |
| 2026-08-28 | @BPharmCatalyst | +0.55 | Reports encouraging Phase 2/3 interim data and financing of up to $50M | · | tweet ↗ |
| 2026-08-28 | @OTR444 | +0.25 | Momentum watchlist summarizes catalysts for the first six names; the source list exceeds the six-ticker cap. | · | tweet ↗ |
| 2026-08-28 | @joinlegendsonly | +0.25 | Describes QNRX's 37% premarket rise as constructive and gives resistance and downside levels. | · | tweet ↗ |
| 2026-08-28 | @OpenOutcrier | +0.50 | Quoin reported interim Phase 2/3 QRX003 data as shares rose 40.1% premarket. | · | tweet ↗ |
| 2026-08-28 | @Briefingcom | -0.15 | QNRX announced private-placement financing of up to $50 million. | · | tweet ↗ |
| 2026-08-28 | @Briefingcom | +0.45 | Reports the largest named premarket gaps, capped at six tickers. | · | tweet ↗ |
| 2026-08-28 | @AlertsAndNews | +0.00 | Presents a morning ticker watchlist without a directional setup. | · | tweet ↗ |
| 2026-08-28 | @CrweWorld | -0.35 | Reports private-placement financing of up to $50 million, implying potential dilution. | · | tweet ↗ |
| 2026-08-28 | @timothysykes | +0.75 | Highlights QNRX's completed premarket rise from the $6s to the $10s. | · | tweet ↗ |
| 2026-08-28 | @BioStocks | -0.30 | Quoin announces a $50 million PIPE priced at $4.88 per ADS. | · | tweet ↗ |
| 2026-08-28 | @BioStocks | +0.65 | QNRX reports statistically significant positive interim Phase 2/3 data in the first six patients. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.